| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-10 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.27 | 6e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |